136 related articles for article (PubMed ID: 34319547)
1.
Englert H; Richards BL; Angelides S; Kumar V; Spencer D; Howe G; Manolios N
Ann Nucl Med; 2021 Oct; 35(10):1157-1166. PubMed ID: 34319547
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD).
Bodolay E; Szekanecz Z; Dévényi K; Galuska L; Csípo I; Vègh J; Garai I; Szegedi G
Rheumatology (Oxford); 2005 May; 44(5):656-61. PubMed ID: 15716315
[TBL] [Abstract][Full Text] [Related]
3. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
[TBL] [Abstract][Full Text] [Related]
4. A pilot trial of quantitative Tc-99m HMPAO and Ga-67 citrate lung scans to detect pulmonary vascular endothelial damage and lung inflammation in patients of collagen vascular diseases with active diffuse infiltrative lung disease.
Hang LW; Hsu WH; Tsai JJ; Jim YF; Lin CC; Kao A
Rheumatol Int; 2004 May; 24(3):153-6. PubMed ID: 12838367
[TBL] [Abstract][Full Text] [Related]
5. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
[TBL] [Abstract][Full Text] [Related]
6. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors.
Forestier A; Le Gouellec N; Béhal H; Kramer G; Perez T; Sobanski V; Dubois SM; Lambert M; Hatron PY; Hachulla E; Duhamel A; Matran R; Launay D; Rémy-Jardin M
Semin Arthritis Rheum; 2020 Dec; 50(6):1406-1413. PubMed ID: 32245698
[TBL] [Abstract][Full Text] [Related]
7. 99mTc-MIBI Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study.
Bahtouee M; Saberifard J; Javadi H; Nabipour I; Raeisi A; Assadi M; Eftekhari M
Medicine (Baltimore); 2015 Nov; 94(47):e2082. PubMed ID: 26632717
[TBL] [Abstract][Full Text] [Related]
8. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.
Gargani L; Bruni C; De Marchi D; Romei C; Guiducci S; Bellando-Randone S; Aquaro GD; Pepe A; Neri E; Colagrande S; Falaschi F; Moggi-Pignone A; Pingitore A; Matucci-Cerinic M
Clin Rheumatol; 2021 May; 40(5):1903-1912. PubMed ID: 33161470
[TBL] [Abstract][Full Text] [Related]
9. Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults With Early Diffuse Cutaneous Systemic Sclerosis.
Bernstein EJ; Jaafar S; Assassi S; Domsic RT; Frech TM; Gordon JK; Broderick RJ; Hant FN; Hinchcliff ME; Shah AA; Shanmugam VK; Steen VD; Khanna D
Arthritis Rheumatol; 2020 Nov; 72(11):1892-1896. PubMed ID: 32583956
[TBL] [Abstract][Full Text] [Related]
10. Esophageal involvement and pulmonary manifestations in systemic sclerosis.
Marie I; Dominique S; Levesque H; Ducrotté P; Denis P; Hellot MF; Courtois H
Arthritis Rheum; 2001 Aug; 45(4):346-54. PubMed ID: 11501722
[TBL] [Abstract][Full Text] [Related]
11. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
[TBL] [Abstract][Full Text] [Related]
12. Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis.
Richard M; Cox D; Earle L; Varga J
Clin Nucl Med; 1998 Jan; 23(1):19-25. PubMed ID: 9442960
[TBL] [Abstract][Full Text] [Related]
13. Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents.
Yang DJ; Kim CG; Schechter NR; Azhdarinia A; Yu DF; Oh CS; Bryant JL; Won JJ; Kim EE; Podoloff DA
Radiology; 2003 Feb; 226(2):465-73. PubMed ID: 12563141
[TBL] [Abstract][Full Text] [Related]
14. Quantitative computed tomography assessment for systemic sclerosis-related interstitial lung disease: comparison of different methods.
Ufuk F; Demirci M; Altinisik G
Eur Radiol; 2020 Aug; 30(8):4369-4380. PubMed ID: 32193641
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate antigen 15.3 as a serum biomarker of interstitial lung disease in systemic sclerosis patients.
Celeste S; Santaniello A; Caronni M; Franchi J; Severino A; Scorza R; Beretta L
Eur J Intern Med; 2013 Oct; 24(7):671-6. PubMed ID: 23697634
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: Cut-off point definition for the presence of significant pulmonary fibrosis.
Tardella M; Di Carlo M; Carotti M; Filippucci E; Grassi W; Salaffi F
Medicine (Baltimore); 2018 May; 97(18):e0566. PubMed ID: 29718851
[TBL] [Abstract][Full Text] [Related]
17. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
Pinal-Fernandez I; Pallisa-Nuñez E; Selva-O'Callaghan A; Castella-Fierro E; Simeon-Aznar CP; Fonollosa-Pla V; Vilardell-Tarres M
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S136-41. PubMed ID: 26315813
[TBL] [Abstract][Full Text] [Related]
18. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
[TBL] [Abstract][Full Text] [Related]
19. Study of the Correlation between HRCT Semi-quantitative Scoring, Concentration of Alveolar Nitric Oxide, and Clinical-functional Parameters of Systemic Sclerosis-induced Interstitial Lung Disease.
Hoang-Duc H; Pham-Huy Q; Vu-Minh T; Duong-Quy S
Yale J Biol Med; 2020 Dec; 93(5):657-667. PubMed ID: 33380926
[No Abstract] [Full Text] [Related]
20.
Liu Y; Zhang Q; Zhang Y; Wang J; Wu Y; Yang G; Shi J; Wang F; Xu Z; Jing H
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
